Datamonitor - Pharmaceuticals and Healthcare

Stakeholder Opinions: Diagnostics in Neurology - Predictive biomarkers expand drug revenues
This analysis covers current and future diagnostic techniques in neurological conditions and looks at the impact of developments over the next 10 years on key stakeholders (diagnostic companies, pharmaceutical companies, payers and patients).

Published 7 July 2008 - Report

Commercial and Pipeline Insight: Fibromyalgia - Approvals legitimize condition and expose underserved patient population
This report provides full analysis of the current and future fibromyalgia market, with indication-specific forecasts to 2017 of branded, generic, and key pipeline drugs in the seven major markets (US, Japan, France, Germany, Italy, Spain and the UK).

Published 2 July 2008 - Report

Commercial and Pipeline Insight: Vaccines for Adults and the Elderly - New blockbuster opportunities ahead
Assessment and forecast of the emerging and fast growing markets for pneumococcal and varicella zoster vaccines as well as boosters.

Published 2 July 2008 - Report

Fibromyalgia Market Forecasts
Indication- and region-specific sales value and volume forecasts for marketed fibromyalgia brands, generics, and key pipeline products in the US, 5EU, and Japan from 2008 to 2017.

Published 2 July 2008 - Interactive Model

Schering-Plough Corporation: PharmaVitae Profile
Analysis of Schering-Plough's corporate strategy, marketed portfolio, pipeline potential and financial position in 2007 and to 2013

Published 2 July 2008 - Company Report

Stakeholder Opinions: Novel Therapeutic Approaches in Cardiovascular Medicine - Lack of market prospects for biologics expose an opportunity for cell and gene therapies

Published 2 July 2008 - Report

AstraZeneca plc: PharmaVitae Profile

Published 1 July 2008 - Company Report

Bayer Schering Pharma AG: PharmaVitae Profile

Published 1 July 2008 - Company Report

Johnson & Johnson: PharmaVitae Profile

Published 1 July 2008 - Company Report

Stakeholder Insight: Asthma - Over-prescribing is common in intermittent and mild forms of asthma

Published 1 July 2008 - Report

Wyeth: PharmaVitae Profile